Related references
Note: Only part of the references are listed.Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study
Erik E. Folch et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus US Preventive Services Task Force Eligibility Criteria, 2005-2015
Li C. Cheung et al.
ANNALS OF INTERNAL MEDICINE (2018)
Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer
David Feller-Kopman et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Comparison of Segmentectomy and Lobectomy in Stage IA Adenocarcinomas
Ze-Rui Zhao et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Navigation bronchoscopy for diagnosis and small nodule location
Juan A. Munoz-Largacha et al.
JOURNAL OF THORACIC DISEASE (2017)
Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer
Jennifer M. Lobo et al.
CLINICAL GENITOURINARY CANCER (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base
Chi-Fu Jeffrey Yang et al.
ANNALS OF THORACIC SURGERY (2016)
Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer
Anil Vachani et al.
CHEST (2016)
Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial?
Pamela M. Marcus et al.
CLINICAL TRIALS (2016)
Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer
J. Scott Ferguson et al.
BMC PULMONARY MEDICINE (2016)
A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer
Gerard A. Silvestri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Indeterminate Pulmonary Nodules: Risk for Having or for Developing Lung Cancer?
Pierre P. Massion et al.
CANCER PREVENTION RESEARCH (2014)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Establishing the Diagnosis of Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
M. Patricia Rivera et al.
CHEST (2013)
Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer? Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Michael K. Gould et al.
CHEST (2013)
Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial
Nanda Horeweg et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Benefits and Harms of CT Screening for Lung Cancer A Systematic Review
Peter B. Bach et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Cost Impact of Molecular Testing for Indeterminate Thyroid Nodule Fine-Needle Aspiration Biopsies
Linwah Yip et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Cost-Effectiveness of a Novel Molecular Test for Cytologically Indeterminate Thyroid Nodules
Henry Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Management of Lung Nodules Detected by Volume CT Scanning
Rob J. van Klaveren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Health state utilities for non small cell lung cancer
Beenish Nafees et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2008)
Preference-based EQ-5D index scores for chronic conditions in the United States
Patrick W. Sullivan et al.
MEDICAL DECISION MAKING (2006)
Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis
JP Wisnivesky et al.
LUNG CANCER (2005)
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
K Claxton et al.
HEALTH ECONOMICS (2005)
Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling
DJ Spiegelhalter et al.
STATISTICS IN MEDICINE (2003)
Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules
MK Gould et al.
ANNALS OF INTERNAL MEDICINE (2003)
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions - A meta-analysis
MK Gould et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Quality of life and utility in patients with non-small cell lung cancer
S Trippoli et al.
PHARMACOECONOMICS (2001)
Handling uncertainty in cost-effectiveness models
AH Briggs
PHARMACOECONOMICS (2000)
Share Paper
